View Section: Company Analysis
Horizon Therapeutics Rating
HP
HPR.MU stock rating score is 63/100. Horizon Therapeutics is aSomewhat Risky Investment.
The in-depth assessment covers such aspects as the profitability and solvency of the company, management efficiency, and growth sustainability. Our rating serves as an answer to whether the company`s shares are generally reasonable for purchase. The higher company rating score is, the more stock is attractive for investment.
Eyestock Rating
63/100
Moderate score
Rating Breakdown
Profitability score
31
/25
Solvency score
21
/25
Efficiency score
11
/25
Stability score
-1
/25
Horizon Therapeutics PLC Rewards and Warnings
The assessment of the quality of a business is based on quantitative analysis of 10 key financials taken from the company's statements. Pay close attention to the cons, if any, before making a decision.
Financial
Check
Value
Net Profit Margin
12 %
Earnings quality
238 %
Gross Margin
75 %
Horizon Therapeutics PLC's Historical Rating
How has the company's valuation changed in the past?
A quick analysis will help you understand how stable financial indicators are overall.
Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
Discover High-rated Companies
View Section: Valuation